AMLX EPS Estimates
Amylyx Pharmaceuticals, Inc.
$27.98
+$0.95(+3.51%)
42
Overall
40
Value
36
Tech
52
Quality
Market Cap
$3.39B
Volume
253.09K
52W Range
$10.83 - $41.14
Target Price
$39.08
AMLX EPS estimates: the consensus estimate for Amylyx Pharmaceuticals, Inc.'s current fiscal year is -$1.48 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AMLX EPS Estimates
- EPS estimate, current quarter
- $-0.38
- EPS estimate, next quarter
- $-0.37
- EPS estimate, current year
- $-1.48
- EPS estimate, next year
- $-1.40
- EPS growth, 3-year
- +23.29%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.53 |
| 2024 | $-4.43 |
| 2023 | $0.73 |
| 2022 | $-3.39 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMLX | $27.98 | +3.5% | 253.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amylyx Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW